Saturday, January 14, 2017 1:40:59 PM
https://clinicaltrials.gov/ct2/show/study/NCT02981550?view=results
investors slowly seem to realize that BTHCF is highly undervalued.
BTHCF Market Value $8.860.000
BLOZF Market Value $ 51.370.000
yet BTHCF has already started a trial with an advanced stage technology (NA-NOSE). BLOZF hasnt started a trial yet. furthermore FAIMS from yost is not an advanced stage technology. NA-NOSE has gone through trials in 22 different countries with thousands of patients in the past. furthermore the medical market BTHCF is aiming for is WAY larger than the market BLOZF is going for. furthermore we just got the cures act signed (see sticky). BTHCF should be valued higher or at least equal to BLOZF. BTHCF has been valued higher in the past and it will climb back up there imo.
dont get me wrong though... BLOZF will bring huge profits in the end also!
i see BTHCF getting into the $1 usd range.
thats the inventor of NA-NOSE dr. haick with bill gates. that kind of shows what kind of tech this is and what kind of ppl are interested in it... this tech will change the world imo.
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
